We have received multiple requests to hold the Symposium virtually and have managed to organise a hybrid event.

The Symposium’s first day will be devoted to the newest prospects for diagnosing important Genetic Syndromes. A new screening approach became a reality in the last few years; there has been high-speed and fundamental development of clinical genetics and advanced ultrasound technology. This progress has challenged all previously used pathways of screening and diagnosis of chromosomal and genetic conditions because it will allow us to make diagnosis better, earlier, and faster. We can start to diagnose severe fetal conditions already from 10 weeks. Everyone needs to be updated on those imminent developments.

We will extensively review how clinical genetics can be merged with fetal medicine and perform deep immersion in the future combination of NIPT for single gene disorders and expert ultrasound. We will demonstrate how advanced imaging can be helpful in the establishment of proper genetic diagnosis, with particular attention to Noonan syndrome and other critical genetic diseases.

Advanced Fetal Echocardiography is the topic of the second day. This unique event is designed for fetal medicine and ultrasound professionals dealing with high-risk pregnancies and fetuses with anomalies and syndromes. It will include essential updates on the scanning technique, including the correct use of the newest colour Doppler technologies and crucial tips and ticks, which can improve diagnostic effectiveness. We will have comprehensive discussions on genetic conditions strongly associated with CHD, especially 22q deletion and an exclusive presentation on scanning the hearts for fetuses with severe extracardiac anomalies.

The Symposium will include lectures, high-quality video presentations and discussions of unusual and complicated cases.

The Symposium will be live- streamed from our venue in the City of London and also recorded with recording access for delegates for 30 days.